Combined metabolic activators to treat mitochondrial dysfunction Mitochondrial dysfunction is a common feature of many human diseases and is emerging as a therapeutic target. Systems biology and multiomics approaches have revealed that Involvement of impaired carnitine induced fatty acid oxidation in experimental and human diabetic kidney disease Role of carnitine in disease Nutrition & Metabolism Springer Nature Link Mitochondrial dysfunction caused by fatty acids and acylcarnitines Download Scientific Diagram l Carnitine reduces reactive oxygen species endoplasmic reticulum stress and maintains mitochondrial function during autophagy mediated cell apoptosis in perfluorooctanesulfonate treated renal tubular cells Scientific Reports